Purchase Order HHSN302201300036P

<p>The National Human Genome Research Institute awarded a purchase order to Roche Diagnostics Corporation for $5,940.00 on January 15, 2014, with final completion on February 15, 2014. Place of performance is North Bethesda, Maryland. The order is firm fixed price with no set-aside category. The specific scope of goods or services procured is not detailed in the source documentation.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Roche Diagnostics Corporation on February 19, 2016, with a ceiling value of $6,324.80 and firm fixed pricing. Performance is located in Bethesda, Maryland. The order was set to complete on December 23, 2020.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Roche Diagnostics Corporation on May 5, 2015, with a ceiling value of $3,689.35 under firm fixed-price terms. Performance is located in North Bethesda, Maryland, with a completion date of June 5, 2015. The specific goods or services procured are not detailed in the source material.</p>

This $9,173 firm fixed price purchase order was awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the U.S. Department of Health and Human Services, to Roche Diagnostics Corporation on August 22, 2016. The award does not have a set-aside designation. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services, has provided critical care analyzers, reagents, test kits,...

This federal contract award was made by the National Human Genome Research Institute (NHGRI), a civilian agency, to Roche Diagnostics Corporation. The $23,500 fixed-price purchase order is for the delivery of unspecified products or services from Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated items. The contract has no set-aside designation. Roche Diagnostics has previously received awards from the Department of...

<p>The National Human Genome Research Institute awarded a purchase order to the University of Rochester for testing kits valued at $1,495.24, effective September 20, 2016, with ultimate completion by December 21, 2020. Performance takes place in Rochester, New York. The order carries firm fixed-price terms and uses no small business set-aside.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Beckman Coulter, Inc. valued at $6,243.00 on January 31, 2018, with ultimate completion on January 31, 2019.</p> <p>The order is a firm fixed price purchase with no set-aside designation. Place of performance is Bethesda, Maryland. The source does not specify the goods or services being procured under this order.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $18,816.00 on August 31, 2018, with ultimate completion on September 28, 2018. Place of performance is Bethesda, Maryland. The order is priced as firm fixed price with no set-aside used. The source does not specify the items or services procured.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $4,452.00 on September 15, 2017, for firm fixed price commercial items. Place of performance is Bethesda, Maryland. The order has an ultimate completion date of December 31, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $18,551.24 on January 30, 2018, with an ultimate completion date of February 21, 2019. The order covers laboratory instrumentation, reagents, and consumables. Place of performance is Bethesda, Maryland. The contract carries firm fixed price and no small business set-aside designation.</p>